Frontera Health Announces Launch and Seed Financing

Gunderson Dettmer represented client Frontera Health, a pioneer in advancing health equity through AI-enabled autism care, in its launch and $32 million Seed financing co-led by Lux Capital and Lightspeed Venture Partners. The company introduced its revolutionary, multi-modal Frontera Digital Phenotyping solution, an AI-powered digital phenotyping technology that transforms how children access and receive treatment. 

In the announcement of its launch and Seed, Frontera Health CEO and co-founder Amol Deshpande said, "As a parent of a son with autism, I saw firsthand how challenging the system is for clinicians. Faster diagnoses and accelerated care lead directly to better outcomes later in life. We're proud to work with BCBAs to empower them to bring quality care to more communities, especially rural and underserved communities that have historically been overlooked."

The Gunderson Dettmer deal team was led by Jay Hachigian and included Alexandra Noymer, Jordana Douglas and Kelvin Chan.

Companies
Frontera Health
Lux Capital
Lightspeed Venture Partners